Background -The efficacy ofan antibiotic is usuafly predicted from serum levels and
the lung tissue concentrations may be more informative. This study compares concentrations of amoxycillin and clavulanate in serum, epithelial lining fluid (ELF), alveolar macrophages, and bronchial mucosa in 15 adults. Methods -Amoxycillin 500mg and clavulanic acid 250 mg were given 1-2 hours before diagnostic bronchoscopy for haemoptysis or radiological abnormality. Mucosal biopsy samples were taken from macroscopically normal sites, alveolar macrophages harvested by lavage, and ELF volume derived from urea concentrations in bronchial lavage fluid and blood. Amoxycillin was assayed by inhibition of growth of Micrococcus lutea, and clavulanate (in serum, ELF, and bronchial mucosa) by inhibition of growth of Kiebsiella pneumoniae; in macrophages clavulanate was measured by high performance liquid chromatography. Results -The median concentrations in serum were 6*90 mgIl for amoxycillin and 5-25 mgIl for clavulanate. The median bronchialmucosal concentration ofamoxycillin was 2-99 mgnl and of clavulanate was 1-65 mg/I; the median concentrations in ELF were 0*89 and 0-96 mgIl, and in macrophages 0 and 0*76 mg/I, respectively. In macrophages amoxycillin levels were undetectable in 10 of 14 subjects (71%); by contrast, only 6 1 agar plate (Unipath, UK). Aliquots of all serum samples, concentrated ELF, mucosal tissue, and macrophages were placed in 5 mm wells cut in this agar and the plate was incubated for 24 hours at 37°C. Zones of inhibition of bacterial growth around patient serum samples were compared with zones produced by standard amoxycillin concentrations in human serum (pH 7 0): zones around mucosal tissue and macrophage samples were compared with those produced by amoxycillin in phosphate buffer (pH 6-6). For assays in concentrated ELF standard amoxycillin preparations were made in 9% sodium chloride. The lower limit of sensitivity for these assays was 0 03 mg/l.
Assay for clavulanic acid in serum, ELF, and mucosa was performed in a similar manner; 16 ml of an overnight broth culture of Kiebsiella pneumoniae (ATCC 29665), diluted to an OD630 of 0-8, was incorporated into a 200 ml No. 2 agar plate (Oxoid, Basingstoke, UK) containing piperacillin at a concentration of 80 mg/l. Samples were incubated in 5 mm wells for 24 hours at 37°C. As described above, zones of inhibition were compared with those produced by standard clavulanate concentrations in human serum (pH 7-0) and 9% sodium chloride. The lower limit of sensitivity for these assays was 0-02 mg/I.
In these systems negative control preparations had no inhibitor-y effect on the assay organisms. The between assay coefficients of variation were 11-4% for both assays. In this system the amoxycillin does not interfere with the assay for clavulanic acid. Recovered salicylamide gave a coefficient of variation of 10-0% and clavulanate 12-5%, with satisfactory resolution of the two compounds.
The between-run coefficient of variation was 6-8% (at 0-25 and 0-1 mg/l) and the lower limit of sensitivity was 0-0 125 mg/I. tissue concentrations of antibiotics occur in discrete compartments ofthe lung (mucosa and submucosa, alveolar macrophages, epithelial lining fluid, and sputum). The alveolar membrane is thus relatively impermeable to antibiotics owing to the presence of many tight junctions (zonulae occludentes) 112' and the capillary endothelium which separates the submucosa from blood, being non-fenestrated,22 23 is also less permeable than the fenestrated capillaries of other organs.24 Measured concentrations in each compartment depend on the rates of penetration and clearance: the lipophilicity, pH, molecular weight, and protein binding of the drug also influence these processes. 25 In acute bronchitis and acute exacerbations of chronic obstructive airways disease and bronchiectasis bacteria are found within the lumen of the airways, at the mucosal cell surface, and within bronchial mucosal tissue.26 In pneumonia they are also chiefly intraluminal: the ELF and alveolar macrophages appear to be important locations.27 These organisms are therefore separated from blood by significant barriers to antibiotic diffusion but, in some cases, antibiotics may be secreted into the bronchial lumen by epithelial cells. Measurement of antibiotic concentrations in sputum is technically difficult -for example, sputum is frequently contaminated by saliva into which antibiotics such as ,B-lactams penetrate only poorly, or by blood. Bronchoalveolar lavage allows the measurement of antibiotic levels in ELF and alveolar macrophages, as well as in bronchial secretions, sputum, and lung tissue.3435 For practical purposes the ELF is defined as the fluid that lines the small airways distal to the point of impaction of the tip of the bronchoscope that is recovered by BAL. It is a complex mixture of solutes and anti-inflammatory cells, present in both healthy and infected people, bathing the terminal bronchioles, alveoli, and alveolar macrophages.
Results
According to our data serum antibiotic concentrations show a partial correlation with those in bronchial mucosa, but not with ELF or macrophage levels. There is no reason, as far as we know, to expect a correlation between serum and macrophage concentrations, but in the case of ELF such a relationship might certainly be predicted. However, technical problems in processing BAL fluid cause a significant variation in. antibiotic levels, particularly resulting from the movement of solute and solvent across the alveolar-capillary membrane. For example, vigorous suction during lavage promotes the efflux of urea into the aspirate, artificially increasing the estimated volume of ELF and thus depressing the derived drug concentrations; the antibiotics, especially clavulanic acid, are unstable at physiological temperatures. Despite the care that we have taken to standardise the procedures used in this study to keep dwell times to a minimum and to freeze dry all specimens (or store them at -70°C) before assay, we therefore believe that a correlation would always be difficult to demonstrate in ELF and macrophages.
However, the other drugs used during bronchoscopy (atropine, lignocaine and midazolam) are unlikely to have influenced the distribution or activity of the antibiotics. Atropine certainly reduces the volume of bronchial secretions but is not known to have any effect on ELF, while lignocaine, though exerting its pharmacological effects on cell membranes, has not been reported to alter antibiotic uptake by pulmonary tissues.
There is now considerable interest in the importance of intracellular infections in the lung with such pathogens as Legionella pneumophila, Chlamydia pneumoniae, and atypical mycobacteria, and in the special problems of antimicrobial delivery to these sites ofinfection. In such infections penetration of macrophages is an important property of antibiotics, but it is not clear whether this penetration occurs in the alveolar lumen, or whether circulating monocyte-derived macrophages acquire the drug before migrating to the alveolar compartment. Beta 
